LY307161 SR, a long-acting GLP-1 analog, improved glycemic control in patients with type 2 diabetes

被引：0
|
作者：
Trautmann, M
Chen, CF
Chappell, J
Dananberg, J
Patterson, B
Klausmann, G
Kapitza, C
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A136 / A136
页数：1
相关论文
共 50 条
  • [41] Semaglutide - a novel long-acting GLP-1 receptor agonist with proven reduction in cardiovascular events in type 2 diabetes
    Seufert, Jochen
    Nauck, Michael A.
    Gallwitz, Baptist
    DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (02) : 141 - 148
  • [42] Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide (Syncria®), a long-acting GLP-1 mimetic, in subjects with type 2 diabetes
    Stewart, Murray W.
    Matthews, Jessica
    De Boever, Erika H.
    Dobbins, Robert L.
    Hodge, Rebecca J.
    Walker, Susan E.
    Holland, Claire H.
    Bush, Mark A.
    DIABETES, 2008, 57 : A154 - A154
  • [43] Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data
    Chudleigh, Richard A.
    Platts, Julia
    Bain, Stephen C.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 433 - 438
  • [44] Oral GLP-1 Analog for Type 2 Diabetes on the Horizon
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (06): : 539 - 539
  • [45] THE IMPACT OF LY2189265 (GLP-1 ANALOG) ON GLYCEMIC CONTROL IN HISPANIC AND NON-HISPANIC CAUCASIANS WITH UNCONTROLLED TYPE 2 DIABETES: AN EGO STUDY ANALYSIS
    Noriega, J.
    Botros, F.
    Threlkeld, R.
    Shu, J.
    Anderson, J.
    Glass, L.
    Bastyr, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 644 - 644
  • [46] Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery
    Yang, Peng-Yu
    Zou, Huafei
    Chao, Elizabeth
    Sherwood, Lance
    Nunez, Vanessa
    Keeney, Michael
    Ghartey-Tagoe, Esi
    Ding, Zhongli
    Quirino, Herlinda
    Luo, Xiaozhou
    Welzel, Gus
    Chen, Guohua
    Singh, Parminder
    Woods, Ashley K.
    Schultz, Peter G.
    Shen, Weijun
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (15) : 4140 - 4145
  • [47] Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice
    Morieri, Mario Luca
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 4221 - 4234
  • [48] The combination of a long acting GLP-1 analog (E-XTEN; VRS-859) and long acting glucagon (AMX-808) for superior weight loss and glycemic control in treatment of type 2 diabetes and obesity
    Cleland, Jeffrey L.
    Geething, Nathan
    To, Wayne
    Spink, Benjamin
    Campbell, Andrew
    Lee, Louise
    Yao, Yi
    Silverman, Joshua
    ENDOCRINE JOURNAL, 2010, 57 : S362 - S362
  • [49] A Phase 2 Evaluation of a Novel GLP-1 Analog Ecnoglutide (XW003) for Glycemic Control in Adults with Type 2 Diabetes
    Zhu, Dalong
    Qin, Hong H.
    Zheng, Qing
    Ning, Jing
    Zhu, Zhiyi
    Guo Mengying
    Bu, Yue
    Jones, Catherine
    Fenaux, Martijn
    Xu, Susan
    Junaidi, Mohammed K.
    DIABETES, 2023, 72
  • [50] Albiglutide, a Long-Acting GLP-1 Receptor Agonist, Improves Glycemia in Type 2 Diabetes: Time-Course Analysis
    Reusch, Jane E. B.
    Rosenstock, Julio
    Bush, Mark A.
    Yang, Fred
    Stewart, Murray W.
    DIABETES, 2009, 58 : A123 - A123
12345